ZIMMER BIOMET HOLDINGS, INC. (ZBH) Options Risk Score

Run a full ZBH options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on ZIMMER BIOMET HOLDINGS, INC. (ZBH) right now?

For a 4-week expiry, ZIMMER BIOMET HOLDINGS, INC. (ZBH) carries an options catalyst-risk score of 62 out of 100 (MEDIUM). That score is driven by an upcoming earnings report, 6 recent news items and 13 clinical-trial catalysts falling inside the 4-week window. On TickerRisk's scale 45 to 69 is MEDIUM, meaning something in the 4-week window is worth checking before committing to an expiry. The score measures scheduled event exposure, not the direction ZBH will move.

ZBH shows an IV Rank of 44, near the low end of its one-year range — options are relatively cheap, which favours option buyers over sellers, with a current implied volatility of about 32%. IV Rank answers how ZBH options are priced against their own history, which is the starting point for choosing between selling and buying premium.

ZBH reports on 2026-11-04. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

ZIMMER BIOMET HOLDINGS, INC. (ZBH) current implied volatility and IV Rank

ZIMMER BIOMET HOLDINGS, INC. (ZBH) currently has an IV Rank of 44 with implied volatility around 32%, alongside a TickerRisk options-risk score of 62/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about ZBH's options, see IV Rank explained.

ZIMMER BIOMET HOLDINGS, INC. (ZBH) next earnings date — 2026-11-04

ZIMMER BIOMET HOLDINGS, INC. (ZBH) reports earnings on 2026-11-04 — about 14 days away, which falls inside a typical options expiry window. ZBH's IV Rank is currently 44. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer